Home Cart Sign in  
Chemical Structure| 1014983-00-6 Chemical Structure| 1014983-00-6

Structure of Tildacerfont
CAS No.: 1014983-00-6

Chemical Structure| 1014983-00-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tildacerfont is an orally active corticotropin-releasing factor 1 (CRF1) receptor inhibitor that significantly lowers adrenocorticotropic hormone (ACTH) and adrenal androgen levels. It has good safety and is suitable for research on congenital adrenal hyperplasia.

Synonyms: SPR001; LY2371712

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tildacerfont

CAS No. :1014983-00-6
Formula : C20H26ClN5OS
M.W : 419.97
SMILES Code : CCC(C1=CC(C)=NC2=C(C3=C(Cl)N=C(N4CCOCC4)S3)C(C)=NN12)CC
Synonyms :
SPR001; LY2371712
MDL No. :N/A

Safety of Tildacerfont

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Tildacerfont

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05128942 Congenital Adrenal Hyperplasia... More >>|21-OHD Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-04-25 Spruce Study Site, Sacramento,... More >> California, 95821, United States|Spruce Study Site, San Diego, California, 92123, United States|Spruce Study Site, Chicago, Illinois, 60611, United States|Spruce Study Site, Minneapolis, Minnesota, 55454, United States|Spruce Study Site, Buffalo, New York, 14203, United States|Spruce Study Site, Providence, Rhode Island, 02903, United States|Spruce Study Site, Columbia, South Carolina, 29203, United States|Spruce Study Site, Dallas, Texas, 75231, United States|Spruce Study Site, Edinburg, Texas, 78539, United States|Spruce Study Site, Fort Worth, Texas, 76104, United States|Spruce Study Site, Salt Lake City, Utah, 84113, United States|Spruce Study Site, Charlottesville, Virginia, 22903, United States|Spruce Study Site, Richmond, Virginia, 23284, United States Less <<
NCT03687242 Congenital Adrenal Hyperplasia... More >>|CAH - Congenital Adrenal Hyperplasia|CAH - 21-Hydroxylase Deficiency Less << PHASE2 COMPLETED 2019-09-24 Spruce Biosciences Clinical Si... More >>te, Orange, California, 92868, United States|Spruce Biosciences Clinical Site, San Diego, California, 92123, United States|Spruce Biosciences Clinical Site, Atlanta, Georgia, 30046, United States|Spruce Biosciences Clinical Site, Indianapolis, Indiana, 46202, United States|Spruce Biosciences Clinical Site, Ann Arbor, Michigan, 48109, United States|Spruce Biosciences Clinical Site, Minneapolis, Minnesota, 55414, United States|Spruce Biosciences Clinical Site, Las Vegas, Nevada, 89148, United States|Spruce Biosciences Clinical Site, Philadelphia, Pennsylvania, 19104, United States Less <<
NCT03257462 Congenital Adrenal Hyperplasia... More >>|CAH - Congenital Adrenal Hyperplasia Less << PHASE2 COMPLETED 2019-05-28 Spruce Biosciences Clinical Si... More >>te, Orange, California, 92123, United States|Spruce Biosciences Clinical Site, San Diego, California, 92123, United States|Spruce Biosciences Clinical Site, Melbourne, Florida, 32935, United States|Spruce Biosciences Clinical Site, Atlanta, Georgia, 30046, United States|Spruce Biosciences Clinical Site, Indianapolis, Indiana, 46202, United States|Spruce Biosciences Clinical Site, Ann Arbor, Michigan, 48109, United States|Spruce Biosciences Clinical Site, Minneapolis, Minnesota, 55414, United States|Spruce Biosciences Clinical Site, Las Vegas, Nevada, 89148, United States|Spruce Biosciences Clinical Site, Philadelphia, Pennsylvania, 19104, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.38mL

0.48mL

0.24mL

11.91mL

2.38mL

1.19mL

23.81mL

4.76mL

2.38mL

References

 

Historical Records

Categories